(lp0
S'Celsion Corporation to Hold Year-End 2016 Financial Results Conference Call on ... GlobeNewswire  - Mar 9, 2017 LAWRENCEVILLE, N.J., March 09, 2017  -- Celsion Corporation  announced today that the Company will host a conference call to discuss year-end 2016 financial results and provide an update on its development&nbsp;...Should You Buy Celsion Corporation  On Current Analyst Views? - Fiscal Standard'
p1
aS'Celsion Corporation Reports Year End 2016 Financial Results and Provides ... Yahoo Finance - Mar 16, 2017 LAWRENCEVILLE, N.J., March 16, 2017  -- Celsion Corporation , an oncology drug development company, today announced financial results for the year ended December 31, 2016 and provided an update on its development&nbsp;...'
p2
aS'Buy or Sell? What Analysts Recommends: QuickLogic Corporation , Celsion ... StockNewsJournal - 15 hours ago Celsion Corporation , at its latest closing price of $0.28, it has a price-to-book ratio of 0.74, compared to an industry average at 10.15.'
p3
aS'Celsion Corp. Cancer Medications Insider Buying and Analysis Yahoo Finance - Feb 21, 2017 NEW YORK, NY / ACCESSWIRE / February 21, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies, is covering Celsion Corp.  today, in light of recent&nbsp;...'
p4
aS'Is Now The Right Time To Catch The Celsion Corporation  Knife? Insider Financial - Feb 23, 2017 Celsion Corporation  has been a tough stock to hold over the last few years. Following a high profile run up, and subsequent collapse, back in early 2013, the company has basically deteriorated in value almost painfully slowly, and despite&nbsp;...Insider Trading Activity Celsion Corporation   Director Bought ... - Market ExclusiveCelsion Corporation : Analyst Rating Changes and PT Levels - Post Analyst'
p5
aS"Why Financial Results for Celsion Corporation  Made No Waves StockNewsUnion - Mar 16, 2017 Celsion Corporation  is a nano-cap biotechnology firm based in Lawrenceville, NJ. Celsion develops cancer treatments.Celsion Corporation : A Detailed Look at its Institutional Ownership - Post AnalystCelsion Corporation  to Report Quarterly Earnings: What's in the ... - Post Registrar"
p6
aS'Celsion Corporation  Is Making A Strong Argument Through Its Technicals NY Stock News - 18 hours ago The technicals for Celsion Corporation  has spoken via its technical chart and the message is loud and clear. Based on that message, this is the relevant information necessary to make sense of that current setup.'
p7
aS"What Analysts are Predicting For Amphastar Pharmaceuticals, Inc. (AMPH ... The USA Commerce - Mar 15, 2017 Shares of Amphastar Pharmaceuticals, Inc.  dropped -17.23% to $12.20. During the trading on 03/14/2017, Company's stock ranged from $12.05 to $13.96."
p8
aS'Celsion Corporation : Getting Technical With The Stock USA Commerce Daily - 12 hours ago With all other things going on, Celsion Corporation  has been on a free fall - declining -40.74 percent in just three months.'
p9
aS"CELSION CORPORATION  Files An 8-K Results of Operations and ... Market Exclusive - Mar 16, 2017 Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA&nbsp;..."
p10
a.